PATH

PATH

USD

UiPath Inc. Class A Common Stock

$11.600-0.040 (-0.344%)

Precio en Tiempo Real

Tecnología
Software - Infrastructure
Estados Unidos

Gráfico de Precios

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$11.640

Máximo

$11.789

Mínimo

$11.450

Volumen

1.11M

Fundamentos de la Empresa

Capitalización de Mercado

6.2B

Industria

Software - Infrastructure

País

United States

Estadísticas de Negociación

Volumen Promedio

12.99M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $9.38Actual $11.600Máximo $20.95

Informe de Análisis de IA

Última actualización: 24 abr 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

PATH (UiPath Inc. Class A Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: PATH Generate Date: 2025-04-24 11:27:30

Alright, let's break down what's been happening with UiPath stock lately and what the tea leaves (and some computer models) might be suggesting.

Recent News Buzz

Looking at the news headlines from the past few weeks, the vibe seems mostly positive, especially when it comes to UiPath's core business – automation and AI. Just today, there's news about them working more closely with Redis to bring their automation tech to big companies. A little while back, they also announced a cool partnership with Google Cloud to use AI to speed up things like getting medical procedures approved, which sounds pretty impactful.

Now, it's not all sunshine. About a week and a half ago, one analyst over at Mizuho kept their "Neutral" rating on the stock but nudged their price target down a dollar, from $12 to $11. So, you've got some good news about business deals mixed with a slightly cautious view from one analyst. Overall, though, the recent headlines lean towards the positive side, highlighting their AI efforts and partnerships.

Price Check

If you glance at the stock chart over the last few months, it's been a bit of a rollercoaster. The price started the year higher, around the $14 mark, even popping above $15 a couple of times in January and February. Then came a pretty sharp drop in March, pushing it down towards the $10 range.

Lately, the stock has been bouncing around between roughly $10 and $11. The last few trading days show a bit of an uptick, moving from just over $10 to close near $10.87 yesterday.

Now, the AI prediction model is chiming in, and it thinks this recent upward nudge might continue. It's forecasting the price could climb a bit today and keep going up over the next couple of days.

Outlook & Ideas to Consider

Putting the news, the price action, and the AI's forecast together, the picture looks cautiously optimistic for the near term.

The positive news about AI partnerships is right in UiPath's wheelhouse and seems to be generating some good sentiment. The stock price has been beaten down from its earlier highs, and it's currently hanging out near a level that some technical folks might see as potential support (around $10.90). Add to that the AI model predicting further upward movement, and it might suggest a window where some investors could consider getting in or adding to their position.

If you were thinking about this stock, a potential entry point could be right around the current price level, maybe $10.90 or slightly lower if it dips a bit. This aligns with where the stock has found some footing recently and where the AI sees it heading up from.

Of course, you always need a plan for when things don't go your way. A potential stop-loss level to consider for managing risk might be somewhere below the recent lows, perhaps around $9.78, as suggested by some analysis. This level is below the big drop we saw in March and gives the stock some room to move without stopping you out on minor dips, but protects you if it takes another significant leg down. On the flip side, if the AI is right and the price moves up, a potential area to think about taking some profits could be around $11.79, which is another level highlighted in some analyses.

Company Context

Just remember, UiPath is all about automating tasks using software robots, and they're really leaning into AI to make that happen. They serve big industries like finance and healthcare. So, news about using AI in healthcare, like the Google Cloud partnership, is directly relevant to their business and growth strategy. It's also worth noting that while the news and AI prediction look good right now, some fundamental numbers like revenue growth and debt levels aren't stellar, which is something to keep in mind for the longer haul.


Disclaimer: This analysis is based on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. Always do your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

GlobeNewswire

Redis and UiPath Build on Existing Collaboration to Deliver Agentic Automation to Enterprises via On-Premises Solutions

SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Redis, the world's fastest data platform, and UiPath (NYSE:PATH), a leading enterprise automation and AI software company, today expanded their collaboration toward

Ver más
Redis and UiPath Build on Existing Collaboration to Deliver Agentic Automation to Enterprises via On-Premises Solutions
PR Newswire

Veho Adds Veteran Finance Leader Alex Estevez to its Board

Veho, the logistics and technology company that operates one of the largest parcel delivery platforms in the U.S., today announced that veteran...

Ver más
Veho Adds Veteran Finance Leader Alex Estevez to its Board
Analyst Upgrades

Mizuho Maintains Neutral on UiPath, Lowers Price Target to $11

Mizuho analyst Siti Panigrahi maintains UiPath with a Neutral and lowers the price target from $12 to $11.

Ver más
Mizuho Maintains Neutral on UiPath, Lowers Price Target to $11
BusinessWire

UiPath Announces AI Partnership with Google Cloud to Transform Medical Processes

A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% UiPath will demo Vertex AI integration and showcase platform features to unlock

Ver más
UiPath Announces AI Partnership with Google Cloud to Transform Medical Processes

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 28 abr 2025, 23:29

BajistaNeutralAlcista

69.6% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Moderado
Guía de Negociación

Punto de Entrada

$11.59

Toma de Ganancias

$12.47

Stop Loss

$10.42

Factores Clave

PDI 6.7 está por encima de MDI 6.6 con ADX 10.8, lo que sugiere una tendencia alcista
El precio actual está extremadamente cerca del nivel de soporte ($11.56), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 6.2 veces el promedio (158,584), lo que indica una presión de compra extremadamente fuerte
El MACD -0.0039 está por debajo de la línea de señal -0.0001, lo que indica un cruce bajista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.